Literature DB >> 1319061

Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7.

U Beutner1, W N Frankel, M S Cote, J M Coffin, B T Huber.   

Abstract

The murine Mls-1 antigen is the prototype of endogenous superantigens, molecules whose activities lead to deletion of T cells expressing certain T-cell receptor V beta genes from the mature repertoire. However, Mls-1 also stimulates T cells expressing these particular V beta genes (V beta 6, V beta 7, V beta 8.1, and V beta 9) in vitro, making it one of the strongest known T-cell activators. We have recently reported that the Mls-1 gene is closely linked to the endogenous mammary tumor virus Mtv-7. We now demonstrate that Mls-1 is encoded by the open reading frame in the U3 region of the long terminal repeat of Mtv-7. However, control of expression of this molecule seems complex, depending on the promoter used for the transfection experiments. The sequence of the Mtv-7 open reading frame differs from all other known mammary tumor virus open reading frame sequences in the 3' end, suggesting that the T-cell receptor V beta specificity is conferred by the C terminus of the molecule. The predicted structure of the protein encoded by the open reading frame is consistent with a type II transmembrane molecule where the C terminus is extracellular.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319061      PMCID: PMC49306          DOI: 10.1073/pnas.89.12.5432

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A maternally inherited superantigen encoded by a mammary tumour virus.

Authors:  P Marrack; E Kushnir; J Kappler
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

2.  Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells.

Authors:  D Woodland; M P Happ; J Bill; E Palmer
Journal:  Science       Date:  1990-02-23       Impact factor: 47.728

3.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

4.  Macrophages and T cells do not express Mlsa determinants.

Authors:  I J Molina; N A Cannon; R Hyman; B T Huber
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

5.  Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene.

Authors:  J E Majors; H E Varmus
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

6.  A linkage map of endogenous murine leukemia proviruses.

Authors:  W N Frankel; J P Stoye; B A Taylor; J M Coffin
Journal:  Genetics       Date:  1990-02       Impact factor: 4.562

7.  The NXSM recombinant inbred strains of mice: genetic profile for 58 loci including the Mtv proviral loci.

Authors:  E M Eicher; B K Lee
Journal:  Genetics       Date:  1990-06       Impact factor: 4.562

8.  Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes.

Authors:  P J Dyson; A M Knight; S Fairchild; E Simpson; K Tomonari
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

9.  Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice.

Authors:  W N Frankel; C Rudy; J M Coffin; B T Huber
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

10.  Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene.

Authors:  C Brandt-Carlson; J S Butel
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more
  34 in total

1.  Complete Nucleotide Sequence of Mouse Mammary Tumor Virus from JYG Chinese Wild Mice: Absence of Bacterial Insertion Sequences in the Cloned Viral gag Gene.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

Review 2.  Virus-encoded superantigens.

Authors:  B T Huber; P N Hsu; N Sutkowski
Journal:  Microbiol Rev       Date:  1996-09

3.  Functional analysis of Mycoplasma arthritidis-derived mitogen interactions with class II molecules.

Authors:  C Bernatchez; R Al-Daccak; P E Mayer; K Mehindate; L Rink; S Mecheri; W Mourad
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain.

Authors:  J Arroyo; E Winchester; B S McLellan; B T Huber
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 5.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.

Authors:  F U Reuss; J M Coffin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Exogenous Mtv-7 superantigen transgene expression in major histocompatibility complex class II I-E- mice reconstituted with embryonic stem cell-derived hematopoietic stem cells.

Authors:  C A Chambers; J Kang; J Pawling; B Huber; N Hozumi; A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Mammary gland expression of mouse mammary tumor virus is regulated by a novel element in the long terminal repeat.

Authors:  W Qin; T V Golovkina; T Peng; I Nepomnaschy; V Buggiano; I Piazzon; S R Ross
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 9.  Role of the T cell receptor alpha-chain in superantigen recognition.

Authors:  M A Blackman; D L Woodland
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

10.  Evidence that the murine AIDS defective virus does not encode a superantigen.

Authors:  L Doyon; C Simard; R P Sékaly; P Jolicoeur
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.